Cargando…
Prevention and treatment of COVID‐19 disease by controlled modulation of innate immunity
The recent outbreak of coronavirus disease 2019 (COVID‐19), triggered by the severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) poses an enormous threat to global public health and economies. Human coronaviruses normally cause no or mild respiratory disease but in the past two decades, pot...
Autores principales: | Schijns, Virgil, Lavelle, Ed C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7280664/ https://www.ncbi.nlm.nih.gov/pubmed/32438473 http://dx.doi.org/10.1002/eji.202048693 |
Ejemplares similares
-
Innate immune signaling and immunothrombosis: New insights and therapeutic opportunities
por: Ryan, Tristram A. J., et al.
Publicado: (2022) -
Fumarate hydratase inhibition activates innate immunity via mitochondrial nucleic acid release
por: Li, Xiang, et al.
Publicado: (2023) -
Type I interferon signaling deficiency results in dysregulated innate immune responses to SARS‐CoV‐2 in mice
por: Ogger, Patricia P., et al.
Publicado: (2022) -
Innate lymphoid cells and cancer: Role in tumor progression and inhibition
por: Yuan, Xiaodong, et al.
Publicado: (2021) -
Immune modulation of HLA-G dimer in maternal-fetal interface
por: Kuroki, Kimiko, et al.
Publicado: (2007)